Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-745-0046
Dr. Altan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015- Yale-New Haven Medical CenterResidency, Internal Medicine, 2009 - 2012
Ankara University FOMClass of 2003
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
TX State Medical License 2016 - 2027
AL State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Publications & Presentations
PubMed
- Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study.Amgad Muneer, Eman Showkatian, Maliazurina B Saad, Lingzhi Hong, Shenduo Li
Cancer Letters. 2026-09-28 - Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L).Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, Gilberto de Castro Jr, Michael Thomas
Journal of Thoracic Oncology. 2026-07-10 - Accelerating Lung Cancer Management Through Previsit Liquid Biopsy: Results From the LUNG-FAST Pilot Study.Eric K Singhi, Natalie Sanchez, Natalie Vokes, Don L Gibbons, Mehmet Altan
Clinical Lung Cancer. 2026-06-30
Press Mentions
MD Anderson Research Highlights for January 9, 2025January 9th, 2025- New Class of Biomarkers Predicts Cancer Patient Treatment ResponseMay 26th, 2023
- MD Anderson Dermatologist & Oncologist Collaborate to Treat VitiligoDecember 13th, 2021
Grant Support
- Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney diseaseUNIVERSITY OF TEXAS MED BR GALVESTON2024–2028
Professional Memberships
- Associate
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
